Developing a Replicable Cardiogenetic Care Model: Insights from the Saguenay-Lac-Saint-Jean Founder Population

构建可复制的心脏遗传护理模式:来自萨格奈-拉克-圣让创始人人群的启示

阅读:1

Abstract

Saguenay–Lac-Saint-Jean (SLSJ), a geographically isolated region in Quebec (Canada), harbors a genetically homogeneous population shaped by a triple founder effect and subsequent genetic drift. While founder autosomal recessive disorders are well documented in this population, the genetic basis of hereditary cardiovascular diseases (HCDs) remain underexplored. This study describes the development of a novel cardiogenetic care model and characterizes the regional genetic landscape of HCDs in SLSJ. From October 2014 to December 2024, two patient groups were evaluated at the Cardiogenetics Clinic: (1) individuals affected with cardiomyopathies, arrhythmias, or thoracic aortic disease; and (2) asymptomatic at-risk relatives undergoing predictive testing. Genetic investigations included multigene panel testing and targeted familial variant analysis. A longitudinal clinical database captured clinical and molecular data. The Cardiogenetics clinic evolved from a traditional one-on-one model into two scalable care pathways: the “Individual Trajectory” and the “Group Genetic Counseling Trajectory”. Over 10 years, 443 affected individuals and 294 at-risk relatives were assessed. Six recurrent pathogenic or likely pathogenic variants were identified across multiple unrelated, non-consanguineous French-Canadian families, consistent with allelic enrichment through genetic drift. The clinical database enabled genotype–phenotype correlation and informed cascade testing strategies. This tailored cardiogenetic care model improved access to timely genetic diagnosis, personalized risk management, and family-based preventive care. It presents a scalable framework applicable for other underserved populations and underscores the importance of integrating precision medicine into regional health systems. The identification of recurrent variants enhances understanding of the regional genetic etiology of HCDs and supports future screening efforts. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12687-026-00862-2.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。